177 related articles for article (PubMed ID: 33522283)
1. Effects of amnion derived mesenchymal stem cells on fibrosis in a 5/6 nephrectomy model in rats.
Akan E; Cetinkaya B; Kipmen-Korgun D; Ozmen A; Koksoy S; Mendilcioğlu İ; Sakinci M; Suleymanlar G; Korgun ET
Biotech Histochem; 2021 Nov; 96(8):594-607. PubMed ID: 33522283
[TBL] [Abstract][Full Text] [Related]
2. Effects of Human Placental Amnion Derived Mesenchymal Stem Cells on Proliferation and Apoptosis Mechanisms in Chronic Kidney Disease in the Rat.
Cetinkaya B; Unek G; Kipmen-Korgun D; Koksoy S; Korgun ET
Int J Stem Cells; 2019 Mar; 12(1):151-161. PubMed ID: 30595007
[TBL] [Abstract][Full Text] [Related]
3. Netrin-1 attenuates the progression of renal dysfunction by blocking endothelial-to-mesenchymal transition in the 5/6 nephrectomy rat model.
Bai J; Hao J; Zhang X; Cui H; Han J; Cao N
BMC Nephrol; 2016 May; 17(1):47. PubMed ID: 27176224
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
Wang DT; Huang RH; Cheng X; Zhang ZH; Yang YJ; Lin X
Int Immunopharmacol; 2015 May; 26(1):4-12. PubMed ID: 25744602
[TBL] [Abstract][Full Text] [Related]
5. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
Song J; Meng L; Li S; Qu L; Li X
Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model.
He J; Wang Y; Sun S; Yu M; Wang C; Pei X; Zhu B; Wu J; Zhao W
Nephrology (Carlton); 2012 Jul; 17(5):493-500. PubMed ID: 22369283
[TBL] [Abstract][Full Text] [Related]
7. BMSC-derived exosomes protect against kidney injury through regulating klotho in 5/6 nephrectomy rats.
Wan F; Yang RC; Tang YW; Tang XL; Ye T; Zheng J; Zhang HQ; Lin Y
Eur J Med Res; 2022 Jul; 27(1):118. PubMed ID: 35820962
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of miRNA-containing extracellular vesicles derived from mesenchymal stromal cells of old rats on renal function in chronic kidney disease.
Wang Y; Guo YF; Fu GP; Guan C; Zhang X; Yang DG; Shi YC
Stem Cell Res Ther; 2020 Jul; 11(1):274. PubMed ID: 32641100
[TBL] [Abstract][Full Text] [Related]
9. Periodontitis deteriorates renal fibrosis and macrophage infiltration in rats with chronic kidney disease.
Lee YS; Kim AR; Jeon YE; Bak EJ; Yoo YJ
Oral Dis; 2024 Apr; 30(3):1497-1505. PubMed ID: 36905098
[TBL] [Abstract][Full Text] [Related]
10. Conditioned Medium from Human Amnion-Derived Mesenchymal Stem Cells Regulates Activation of Primary Hepatic Stellate Cells.
Fu Q; Ohnishi S; Sakamoto N
Stem Cells Int; 2018; 2018():4898152. PubMed ID: 30402110
[TBL] [Abstract][Full Text] [Related]
11. Resistance training attenuates inflammation and the progression of renal fibrosis in chronic renal disease.
Souza MK; Neves RVP; Rosa TS; Cenedeze MA; Arias SCA; Fujihara CK; Bacurau RFP; Câmara NOS; Moraes MR; Pacheco E Silva Filho A
Life Sci; 2018 Aug; 206():93-97. PubMed ID: 29787737
[TBL] [Abstract][Full Text] [Related]
12. Tempol, a Superoxide Dismutase-Mimetic Drug, Ameliorates Progression of Renal Disease in CKD Mice.
Ding W; Wang B; Zhang M; Gu Y
Cell Physiol Biochem; 2015; 36(6):2170-82. PubMed ID: 26279424
[TBL] [Abstract][Full Text] [Related]
13. Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation.
Chang JW; Tsai HL; Chen CW; Yang HW; Yang AH; Yang LY; Wang PS; Ng YY; Lin TL; Lee OK
J Cell Mol Med; 2012 Dec; 16(12):2935-49. PubMed ID: 22862802
[TBL] [Abstract][Full Text] [Related]
14. Intravenous administration of iPS-MSC
Sheu JJ; Sung PH; Wallace CG; Yang CC; Chen KH; Shao PL; Chu YC; Huang CR; Chen YL; Ko SF; Lee MS; Yip HK
J Cell Mol Med; 2020 Mar; 24(6):3593-3610. PubMed ID: 32061051
[TBL] [Abstract][Full Text] [Related]
15. Delivery of AAV2-CYP2J2 protects remnant kidney in the 5/6-nephrectomized rat via inhibition of apoptosis and fibrosis.
Zhao G; Tu L; Li X; Yang S; Chen C; Xu X; Wang P; Wang DW
Hum Gene Ther; 2012 Jul; 23(7):688-99. PubMed ID: 22260463
[TBL] [Abstract][Full Text] [Related]
16. Metformin arrests the progression of established kidney disease in the subtotal nephrectomy model of chronic kidney disease.
Borges CM; Fujihara CK; Malheiros DMAC; de Ávila VF; Formigari GP; Lopes de Faria JB
Am J Physiol Renal Physiol; 2020 May; 318(5):F1229-F1236. PubMed ID: 32249610
[TBL] [Abstract][Full Text] [Related]
17. FTY720 prevents progression of renal fibrosis by inhibiting renal microvasculature endothelial dysfunction in a rat model of chronic kidney disease.
Ni H; Chen J; Pan M; Zhang M; Zhang J; Chen P; Liu B
J Mol Histol; 2013 Dec; 44(6):693-703. PubMed ID: 23907620
[TBL] [Abstract][Full Text] [Related]
18. The effect of oral protease administration in the rat remnant kidney model.
Sebeková K; Dämmrich J; Krivosíková Z; Heidland A
Res Exp Med (Berl); 1999 Dec; 199(3):177-88. PubMed ID: 10639701
[TBL] [Abstract][Full Text] [Related]
19. [Experimental study of human amniotic mesenchymal stem cell exosome promoting fibroblasts migration through microRNA-135a].
Chen T; Gao S; Hao Y; Zhang F; Tang X; Wei Z; Wang D; Qi J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2020 Feb; 34(2):234-239. PubMed ID: 32030957
[TBL] [Abstract][Full Text] [Related]
20. Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease--role of sclerostin?
Ferreira JC; Ferrari GO; Neves KR; Cavallari RT; Dominguez WV; Dos Reis LM; Graciolli FG; Oliveira EC; Liu S; Sabbagh Y; Jorgetti V; Schiavi S; Moysés RM
PLoS One; 2013; 8(11):e79721. PubMed ID: 24236156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
